Next Article in Journal
Fluorescence Molecular Tomography: Principles and Potential for Pharmaceutical Research
Previous Article in Journal
Nanotechnology and Drug Delivery: An Update in Oncology
Previous Article in Special Issue
Live Cell in Vitro and in Vivo Imaging Applications: Accelerating Drug Discovery
Article Menu

Export Article

Open AccessArticle
Pharmaceutics 2011, 3(2), 186-228; doi:10.3390/pharmaceutics3020186

Design, Synthesis, and Biological Evaluation of PKD Inhibitors

1
Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA
2
Department of Pharmacology and Chemical Biology, University of Pittsburgh, Pittsburgh, PA 15260, USA
3
Department of Pharmacology, University of Virginia, Charlottesville, VA 22908, USA
*
Author to whom correspondence should be addressed.
Received: 17 February 2011 / Revised: 1 April 2011 / Accepted: 19 April 2011 / Published: 21 April 2011
(This article belongs to the Special Issue Drug Discovery Tools)

Abstract

Protein kinase D (PKD) belongs to a family of serine/threonine kinases that play an important role in basic cellular processes and are implicated in the pathogenesis of several diseases. Progress in our understanding of the biological functions of PKD has been limited due to the lack of a PKD-specific inhibitor. The benzoxoloazepinolone CID755673 was recently reported as the first potent and kinase-selective inhibitor for this enzyme. For structure-activity analysis purposes, a series of analogs was prepared and their in vitro inhibitory potency evaluated. View Full-Text
Keywords: protein kinase D; small molecule inhibitor; benzothienothiazepinone; pyrimidines; CID755673; thiazepinothiophenopyrimidinone protein kinase D; small molecule inhibitor; benzothienothiazepinone; pyrimidines; CID755673; thiazepinothiophenopyrimidinone
Figures

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

George, K.M.; Frantz, M.-C.; Bravo-Altamirano, K.; LaValle, C.R.; Tandon, M.; Leimgruber, S.; Sharlow, E.R.; Lazo, J.S.; Wang, Q.J.; Wipf, P. Design, Synthesis, and Biological Evaluation of PKD Inhibitors. Pharmaceutics 2011, 3, 186-228.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top